Insider Transactions Reported by 10 Insiders of BELLICUM PHARMACEUTICALS, INC

Location
Houston, TX

There are no Buy or Sell transactions made by insiders since 03 Feb 2025

BELLICUM PHARMACEUTICALS, INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard A. Fair President and CEO, Director $576,000 15 Aug 2022
Charity Scripture Chief Development Officer $360,000 15 Aug 2022
STEPHEN DAVIS Director $21,600 03 Jan 2023
James M. Daly Director $21,600 03 Jan 2023
Judith Klimovsky V. Director $21,600 03 Jan 2023
Reid M. Huber Director $21,600 03 Jan 2023
Jon P. Stonehouse Director $21,600 03 Jan 2023
JAMES F. BROWN Director $9,360 04 Jan 2022
Charles Grass Principal Accounting Officer 11 May 2021
BAKER BROS. ADVISORS LP 10%+ Owner 22 Nov 2023

Recent Insider Transactions by Companies or Individuals for BELLICUM PHARMACEUTICALS, INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.